Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences. - Wikidata - wikimedia - TriplyDB

Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.

Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.

http://www.wikidata.org/entity/Q42747700

about

The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.Micafungin use in children.Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.Candida parapsilosis, an emerging fungal pathogen Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.Micafungin in the treatment of invasive candidiasis and invasive aspergillosis Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species.KRE5 Suppression Induces Cell Wall Stress and Alternative ER Stress Response Required for Maintaining Cell Wall Integrity in Candida glabrata Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia Micafungin activity against Candida albicans with diverse azole resistance phenotypes.Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.Micafungin for the prophylaxis and treatment of Candida infections.Treatment of invasive candidiasis in the elderly: a review Antifungal Effect of Novel 2-Bromo-2-Chloro-2-(4-Chlorophenylsulfonyl)-1-Phenylethanone against Candida Strains.Pharmacology and antifungal properties of anidulafungin, a new echinocandin.Paradoxical echinocandin activity: a limited in vitro phenomenon?Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility Current perspectives on echinocandin class drugs.Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms.Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.Echinocandin pharmacodynamics: review and clinical implications.Echinocandins: are they all the same?Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.Echinocandins: production and applications.The Eagle-like effect of echinocandins: what's in a name?Antifungal drug resistance among Candida species: mechanisms and clinical impact.Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes.Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.Drug resistance mechanisms and their regulation in non-albicans Candida species.Management of Candida biofilms: state of knowledge and new options for prevention and eradication.Potential Microbiological Effects of Higher Dosing of Echinocandins.Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.Echinocandins in antifungal pharmacotherapy.The postantifungal and paradoxical effects of echinocandins against Candida spp.

P2860

Q27026751-E8613F00-321C-4E27-8D23-BB9589D42A8E Q28533912-E5A9EA5F-1F66-4AED-86F9-34FAEF64B5DD Q28547078-F3688A85-5FF1-4ACE-AC4D-AFAA00F14703 Q30570494-0B2F121D-D9A6-4DF8-85F8-C17468035F39 Q33397111-716573C6-53C2-4BB0-B225-56642F2D4D9A Q34006585-7E4BBA1B-EB18-4A5D-9571-0B8060540317 Q34309395-36929761-AF25-44DC-8ECB-A164942257B5 Q34852747-1537F00D-A971-42CB-BB61-02FDB8E6C1D4 Q34932630-F7BEA690-1074-491E-AC39-26B2C78C2390 Q34932922-051C9E64-0093-4EDC-847B-7E9BAE8F9D23 Q35026516-0160F46B-A00E-4A9F-9706-E80B12C7683E Q35666505-8E4122CC-8AC0-4772-81EB-E501BEF74AE9 Q36094887-CDCF4100-C912-4B71-B16D-9281058B8D31 Q36109051-185900D0-F9F0-43C9-8B25-5D1EB1368995 Q36422666-131DBD38-B8F5-48EB-A9FB-3D2DAD022D47 Q36867925-2409409C-8D7A-4481-BE8E-0811668622AB Q37026730-3AA33980-DE73-4A57-A048-92149367ECBE Q37124868-D9FEA245-F71A-4F1E-A393-CB859829F5FA Q37170218-46AF7F04-DFED-403A-ABFD-5CE383272AF7 Q37201489-B2620FEB-3130-4F2D-849F-95B75052CC7F Q37359613-A209262D-968E-4398-86DB-CFFE69245484 Q37405284-F0E0FE27-8E52-46EA-A8E0-840D970AA8B0 Q37544444-3C69250F-B852-4115-91B1-4C4B89BDEFD6 Q37554055-661643F1-AA9E-4401-8AC4-FC76592D4688 Q37608358-C5356693-EF8A-45A9-A42E-88E61E84701B Q37613000-DEF16640-8EC6-445B-BB0C-5010425E9A51 Q37718385-A6CD0907-AEF2-4136-8FC5-D302C8EF7C55 Q37974743-5EA01B1C-4009-45DB-A152-B0A39BA9A6B8 Q38027469-4EAD37BA-9E1C-46C7-9A75-796225A3CDB5 Q38086769-D08B15AA-4594-476B-B9D7-A300A72F6AA2 Q38153458-6A12E164-EE57-4156-838A-335B8EF10784 Q38511946-A6C30955-9CF5-4BD3-93D5-3E78AB151F7C Q38586680-FCBB1065-2838-4061-88A7-A1AA34FAAF75 Q38603971-C044D204-2A4B-4134-8143-4F9C2900ED94 Q38708362-C4C92314-A11B-41CE-B9E2-229ECCA3FCDB Q38724208-7FFD2FC8-AFF4-494A-8BD0-30FFE8EA083D Q38942828-F6045565-F026-48C2-A884-9582F2C0D4AC Q39230127-F87D81C9-FE7E-4858-9D9E-F4C2A6AD0301 Q39458862-034B625F-80D2-49FF-9714-F94C9E19929C Q39619972-3462DA0B-B4CC-43ED-A8F9-3BF60A6F6065

P2860

Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.

http://www.wikidata.org/entity/Q42747700

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Paradoxical effect of Echinoca ...... a species-related differences.

@en

Paradoxical effect of Echinoca ...... a species-related differences.

@nl

type

label

Paradoxical effect of Echinoca ...... a species-related differences.

@en

Paradoxical effect of Echinoca ...... a species-related differences.

@nl

prefLabel

Paradoxical effect of Echinoca ...... a species-related differences.

@en

Paradoxical effect of Echinoca ...... a species-related differences.

@nl

P1433

Q42747700-31B89B3A-CB17-4E6A-8E59-CCEC2D8D2ED8

P1476

Q42747700-BFD4C9D2-FFAE-4234-AFFD-0AD2822D1B54

P2093

Q42747700-B5EDECDA-077C-46F1-BF92-9BFFDEE6775C

Q42747700-DFE9E6F9-4911-4216-8208-F81BB0CACAFB

Q42747700-FED7E929-118A-4F39-BB3A-EF0DF36A016E

P2860

Q42747700-0290CE53-00FD-4D30-AA7D-AD4ED8797D41

Q42747700-124D9F64-E7A1-47B1-B57B-782E70975EA4

Q42747700-17AE7384-72E3-4609-8AAC-D46D6360D45D

Q42747700-2ACBEACF-F1FA-4D17-AD57-29A5E8922217

Q42747700-398B7E7E-FAB6-447B-B9A6-F9A61BDD6A04

Q42747700-61B23E90-97A7-410C-A007-0055CFA9F800

Q42747700-A8D97E8B-6A8E-44B5-A025-3A2DF5AAAEFA

Q42747700-B1334C52-2AEC-4FE5-BC03-E5ACBC60E602

Q42747700-BF3E21A0-DCD7-46F5-B8FA-C5C4CB2AF26A

Q42747700-CD0CB535-A8E0-41AE-9AC3-EBE4EC146F6A

P304

Q42747700-034C09DF-DA1B-466A-A8DF-3CE40A189711

P31

Q42747700-B58CA505-4A9D-4170-A450-6075DE211A91

P356

Q42747700-D3856750-EA5B-4494-9EBE-9D0C23D217C6

P407

Q42747700-BF05D917-29B3-4CCD-8257-A311094432DB

P433

Q42747700-A39FC44F-1952-4328-8EBB-086F25988D48

P478

Q42747700-A797E4DB-116D-466A-BAC5-84DB8A0379E7

P50

Q42747700-4EDA5A45-C549-4B13-82D2-8CC987D51EA0

P577

Q42747700-F9ED38D0-65F9-40CE-9539-B3DE88866E55

P698

Q42747700-33828A70-B70B-4F23-9FFD-39BD617550BE

P932

Q42747700-6EF41868-05AA-4510-B295-7FAE26DA3B7D

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Paradoxical effect of Echinoca ...... a species-related differences.

@en

P2093

Dimitrios P Kontoyiannis

http://www.w3.org/2001/XMLSchema#string

Georgios Chamilos

http://www.w3.org/2001/XMLSchema#string

Nathaniel Albert

http://www.w3.org/2001/XMLSchema#string

P2860

Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin

Echinocandin antifungal drugs

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.

Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin.

Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.

Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways.

Assessment of the paradoxical effect of caspofungin in therapy of candidiasis

Comparison of caspofungin and amphotericin B for invasive candidiasis.

Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity.

P304

2257-2259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00095-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Russell E. Lewis

P577

2007-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17438060

http://www.w3.org/2001/XMLSchema#string

P932

1891358

http://www.w3.org/2001/XMLSchema#string